Concepedia

Mito Tariveranmoshabad

MT

Statistics

Publications

4

Citations

296

H-Index

4

Active since

2019

Affiliations

Parker Institute for Cancer Immunotherapy(Current)

University of California, Los Angeles

University of Pennsylvania

Mito Tariveranmoshabad is an author at Parker Institute for Cancer Immunotherapy specializing in immunology, cancer immunology, and life sciences.

ORCID

Publications per year

2019–2024

4

Publications

4

Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma

Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi et al. · Science Translational Medicine · 2020 · 130 citations · Full text

, , +14

Potentiating adoptive cell therapy using synthetic IL-9 receptors

Anusha Kalbasi, Mikko Siurala, Leon Su et al. · Nature · 2022 · 115 citations · Full text

, , +17

Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteins

Meredith L. Stone, Jesse Lee, Jae W. Lee et al. · Nature Immunology · 2024 · 36 citations · Full text

, , +12

Temporal Control of the TGF-β Signaling Network by Mouse ESC MicroRNA Targets of Different Affinities

Timothy Kelly, Anneke Brümmer, Nima Hooshdaran et al. · Cell Reports · 2019 · 15 citations · Full text

, , +17

1–4 of 4